E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -93.87% 1,148.49% 1,282.07% 1,655.16% 2,118.08%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -91.87% 897.72% 1,003.75% 1,367.01% 1,793.14%
Operating Income 91.87% -897.72% -1,003.75% -1,367.01% -1,793.14%
Income Before Tax 91.84% -690.51% -547.12% -372.13% -1,091.42%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 91.84% -690.51% -547.12% -372.13% -1,091.42%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 91.84% -690.51% -547.12% -372.13% -1,091.42%
EBIT 91.87% -897.72% -1,003.75% -1,367.01% -1,793.14%
EBITDA -- -- -- 89.25% 29.21%
EPS Basic 96.21% -289.47% -56.86% 12.77% -116.39%
Normalized Basic EPS 96.39% 23.33% 37.50% 51.85% 4.60%
EPS Diluted 85.90% -33.82% 3.00% 10.92% -81.40%
Normalized Diluted EPS 96.39% 2.13% 25.37% 45.26% -12.16%
Average Basic Shares Outstanding 186.67% 421.29% 418.41% 415.47% 290.52%
Average Diluted Shares Outstanding 186.67% 341.16% 322.54% 295.63% 185.69%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings